HYPHENS PHARMA INTERNATIONAL LIMITED
SGD 0.33
52W 0.29
0.33 · 33% of range
0.40
Valuation
Market Cap
100.4M
P/E (TTM)
16.2
Div Yield
P/B
1.4
EPS (TTM)
0.02
FCF Yield
17.1%
Growth & Profitability
Revenue
SGD 177M
-9.2%
5Y CAGR +7.5%
▁▁▂▂▂▂▄▅▇▅
Net Profit
SGD 6M
-44.0%
5Y CAGR -0.3%
▁▁▁▂▁▂▇▄▆▁
Net Margin
3.4%
-2.1 pts
sector median -3.8%
ROE
8.4%
-6.2 pts
sector median 2.9%
Financials
Announcements
Dividends
Buybacks
Corp Actions
Revenue & Profit
Financial Data
| Date | Type | Period | Title | Sentiment |
|---|
Dividend History
| Date | Type | Amount | Currency | Ex-Date | Payment Date |
|---|
Buyback Activity
| Date | Shares | Avg Price | Total ($) | Cumulative |
|---|
| Date | Type | Details |
|---|
HYPHENS PHARMA INTERNATIONAL LIMITED (1J5/SI) — FY2025: Revenue SGD 177M, Profit 6M, EPS 1.97. Data: FY2015-FY2025, Q1, Q2, Q3, Q4 quarterly data.
Historical Annual Data (11 years)
| FY | Revenue (M) | Net Profit (M) | EPS | Total Assets (M) | Total Equity (M) |
|---|---|---|---|---|---|
| FY2025 | 177 | 6 | 1.97 | 124 | 73 |
| FY2024 | 195 | 11 | 3.3 | 136 | 74 |
| FY2023 | 171 | 9 | 2.77 | 121 | 66 |
| FY2022 | 162 | 11 | 3.68 | 114 | 70 |
| FY2021 | 126 | 7 | 2.26 | - | - |